ID
37320
Beschrijving
Study ID: 111592 Clinical Study ID: 111592 Study Title: A Randomized, Double-blind, Placebo-controlled, Doseescalation Study to Assess the Anti-inflammatory Activity, Efficacy, and Safety of Intravenous SB-681323 in Subjects at Risk for Development of Acute Lung Injury or ARDS Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00996840 See https://clinicaltrials.gov/ct2/show/NCT00996840 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 2 Study Recruitment Status: Completed Generic Name: Placebo, SB-681323 Trade Name: N/A Study Indication: Lung Injury, Acute The primary objective of this phase 2 trial is to evaluate the safety and tolerability of intravenous dilmapimod/SB-681323 given in escalating dosages and over different intervals for three days in trauma patients at risk for the development of ALI or ARDS. This study consists of Screening, infusion of dilmapimod/SB-681323 on days 1-3, examination/sampling up to early day 5 (denoted as "Day 3 - 48 hrs") and a Follow-up on day 7. There are four cohorts, cohorts 1 and 3 receive the medication (or placebo) infusion over 4 hours, cohorts 2 and 4 over 24 hours. This form includes Clinical Chemistry and Haematology lab examinations and results and is to be filled in at Screening, on Days 2 and 3 at 0 hrs and Day 3 at 24 hrs (i.e. Day 4 - 0 hrs) and at Follow-Up for all cohorts and for any repeat analyses.
Link
https://clinicaltrials.gov/ct2/show/NCT00996840
Trefwoorden
Versies (1)
- 16-07-19 16-07-19 -
Houder van rechten
GlaxoSmithKline
Geüploaded op
16 juli 2019
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY-NC 3.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
SB-681323 in ALI/ARDS risk patients - NCT00996840
Local Laboratory - Clinical Chemistry and Haematology
- StudyEvent: ODM
Beschrijving
Clinical Chemistry Analysis
Alias
- UMLS CUI-1
- C0008000 (Chemistry, Clinical)
- UMLS CUI-2
- C0022885 (Laboratory Procedures)
- SNOMED
- 269814003
Beschrijving
Fill in the following items for each analysed feature at all visits (except for repeat assessments). The following items are not mandatory for Days 2 and 3 for all cohorts: 16 = Prothrombin Time (PT) 17 = Partial Thromboplastin Time (PTT) 19 = International normalized ratio (INR) 22 = Arterial Blood pH 23 = Serum Estradiol item 22 = Arterial Blood pH is not mandatory for Follow-up Select the appropriate feature for Repeat Analysis. The inclusion of 23 = Serum Estradiol during Screening and Follow-Up is a change to the study.
Datatype
integer
Alias
- UMLS CUI [1,1]
- C0008000 (Chemistry, Clinical)
- UMLS CUI [1,2]
- C0022885 (Laboratory Procedures)
- SNOMED
- 269814003
Beschrijving
Clinical chemistry result type
Datatype
integer
Alias
- UMLS CUI [1,1]
- C0008000 (Chemistry, Clinical)
- UMLS CUI [1,2]
- C1274040 (Result)
- SNOMED
- 394617004
- UMLS CUI [1,3]
- C0332307 (Type - attribute)
- SNOMED
- 261664005
Beschrijving
if applicable
Datatype
float
Alias
- UMLS CUI [1,1]
- C0008000 (Chemistry, Clinical)
- UMLS CUI [1,2]
- C2347373 (Numeric Test Result)
Beschrijving
if applicable
Datatype
text
Alias
- UMLS CUI [1,1]
- C0008000 (Chemistry, Clinical)
- UMLS CUI [1,2]
- C1274040 (Result)
- SNOMED
- 394617004
- UMLS CUI [1,3]
- C2350015 (Data Type -Character)
Beschrijving
Haematology Lab Analysis
Alias
- UMLS CUI-1
- C0022885 (Laboratory Procedures)
- SNOMED
- 269814003
- UMLS CUI-2
- C0018941 (Hematologic Tests)
- SNOMED
- 252275004
Beschrijving
Select the appropriate feature for Repeat Analysis At all other visits, fill in the following items for each analysed feature.
Datatype
integer
Alias
- UMLS CUI [1,1]
- C0022885 (Laboratory Procedures)
- SNOMED
- 269814003
- UMLS CUI [1,2]
- C0018941 (Hematologic Tests)
- SNOMED
- 252275004
Beschrijving
Haematology Lab result type
Datatype
integer
Alias
- UMLS CUI [1,1]
- C0022885 (Laboratory Procedures)
- SNOMED
- 269814003
- UMLS CUI [1,2]
- C0018941 (Hematologic Tests)
- SNOMED
- 252275004
- UMLS CUI [1,3]
- C1274040 (Result)
- SNOMED
- 394617004
- UMLS CUI [1,4]
- C0332307 (Type - attribute)
- SNOMED
- 261664005
Beschrijving
if applicable
Datatype
float
Alias
- UMLS CUI [1,1]
- C0018941 (Hematologic Tests)
- SNOMED
- 252275004
- UMLS CUI [1,2]
- C2347373 (Numeric Test Result)
Beschrijving
if applicable
Datatype
text
Alias
- UMLS CUI [1,1]
- C0018941 (Hematologic Tests)
- SNOMED
- 252275004
- UMLS CUI [1,2]
- C1274040 (Result)
- SNOMED
- 394617004
- UMLS CUI [1,3]
- C2350015 (Data Type -Character)
Similar models
Local Laboratory - Clinical Chemistry and Haematology
- StudyEvent: ODM
C0022885 (UMLS CUI-2)
C0200345 (UMLS CUI [1,2])
C1301732 (UMLS CUI [1,3])
C0200345 (UMLS CUI [1,2])
C0022885 (UMLS CUI-2)
C0022885 (UMLS CUI [1,2])
C1274040 (UMLS CUI [1,2])
C0332307 (UMLS CUI [1,3])
C2347373 (UMLS CUI [1,2])
C1274040 (UMLS CUI [1,2])
C2350015 (UMLS CUI [1,3])
C0018941 (UMLS CUI-2)
C0018941 (UMLS CUI [1,2])
C0018941 (UMLS CUI [1,2])
C1274040 (UMLS CUI [1,3])
C0332307 (UMLS CUI [1,4])
C2347373 (UMLS CUI [1,2])
C1274040 (UMLS CUI [1,2])
C2350015 (UMLS CUI [1,3])
Geen commentaren